Literature DB >> 23302875

Estimating cytomegalovirus growth rates by using only a single point.

Deborah Cromer1, Siok-Keen Tey, Rajiv Khanna, Miles P Davenport.   

Abstract

Calculation of pathogen growth rates is important in understanding the natural history of infection and effects of therapy. However, it is often difficult to estimate pathogen growth because patients are treated immediately upon the detection of infection, leaving only one nonzero untreated reading. Previous approaches have relied on the flawed assumption that pathogen loads just prior to detection are at the assay detection threshold. We have developed a novel method for estimating the pathogen growth rate from a single reading and investigated the initial growth of cytomegalovirus (CMV) in allogeneic hematopoietic stem cell transplant (HSCT) patients. We applied this approach to CMV viral loads measured at least weekly in 122 patients in the 3 months posttransplant. Viral growth rates were estimated by using a modeling approach that accounts for the viral load and the time since the last negative reading. Viral growth rates decreased rapidly within the first week, from 0.72/day (doubling time, 0.96 day) at the point of reactivation to 0.22/day (doubling time, 3.1 days) at 1 week. Results from this method correlated closely with a two-point regression analysis of a subset of 58 patients with detectable subthreshold viral loads immediately prior to overt reactivation. Patients with lymphocyte counts of ≥0.5 × 10(9)/liter had significantly slower viral growth than patients with low lymphocyte counts (0.612/day versus 0.325/day, P < 0.0001). Thus, our novel method of estimating pathogen growth rates reveals a rapid slowing of CMV growth during reactivation in HSCT patients and a significant impact of the lymphocyte count on CMV growth.

Entities:  

Mesh:

Year:  2013        PMID: 23302875      PMCID: PMC3592124          DOI: 10.1128/JVI.02821-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Viral-load kinetics and CMV disease.

Authors:  Y H Kuo; Y L Kuo
Journal:  Lancet       Date:  2000-10-14       Impact factor: 79.321

2.  Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.

Authors:  V C Emery; C A Sabin; A V Cope; D Gor; A F Hassan-Walker; P D Griffiths
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

3.  National serosurvey of cytomegalovirus in Australia.

Authors:  Holly Seale; C Raina MacIntyre; Heather F Gidding; J L Backhouse; Dominic E Dwyer; Lyn Gilbert
Journal:  Clin Vaccine Immunol       Date:  2006-09-06

4.  The dynamics of human cytomegalovirus replication in vivo.

Authors:  V C Emery; A V Cope; E F Bowen; D Gor; P D Griffiths
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

5.  Age-dependent growth rate of primary breast cancer.

Authors:  P G Peer; J A van Dijck; J H Hendriks; R Holland; A L Verbeek
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

6.  Mixed models for longitudinal left-censored repeated measures.

Authors:  Rodolphe Thiébaut; Hélène Jacqmin-Gadda
Journal:  Comput Methods Programs Biomed       Date:  2004-06       Impact factor: 5.428

7.  The risk of malarial infections and disease in Papua New Guinean children.

Authors:  Pascal Michon; Jennifer L Cole-Tobian; Elijah Dabod; Sonja Schoepflin; Jennifer Igu; Melinda Susapu; Nandao Tarongka; Peter A Zimmerman; John C Reeder; James G Beeson; Louis Schofield; Christopher L King; Ivo Mueller
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

8.  Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts.

Authors:  Vincent C Emery; Aycan F Hassan-Walker; Andrew K Burroughs; Paul D Griffiths
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

9.  Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.

Authors:  Michael Boeckh; Wendy Leisenring; Stanley R Riddell; Raleigh A Bowden; Meei-Li Huang; David Myerson; Terry Stevens-Ayers; Mary E D Flowers; Terri Cunningham; Lawrence Corey
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

10.  Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.

Authors:  Arlene E Dent; Elke S Bergmann-Leitner; Danny W Wilson; Daniel J Tisch; Rhonda Kimmel; John Vulule; Peter Odada Sumba; James G Beeson; Evelina Angov; Ann M Moormann; James W Kazura
Journal:  PLoS One       Date:  2008-10-29       Impact factor: 3.240

View more
  4 in total

1.  Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation.

Authors:  S-K Tey; M P Davenport; G R Hill; G A Kennedy; S T Durrant; R Khanna; D Cromer
Journal:  Bone Marrow Transplant       Date:  2014-11-17       Impact factor: 5.483

2.  An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Alberto Talaya; Estela Giménez; María Jesús Pascual; Beatriz Gago; José Luis Piñana; Juan Carlos Hernández-Boluda; Lourdes Vázquez; Magdalena García; David Serrano; Marta Hernández; Eliseo Albert; Carlos Solano; David Navarro
Journal:  Med Microbiol Immunol       Date:  2019-09-03       Impact factor: 3.402

3.  Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children.

Authors:  Arnold Reynaldi; Timothy E Schlub; Kiprotich Chelimo; Peter Odada Sumba; Erwan Piriou; Sidney Ogolla; Ann M Moormann; Rosemary Rochford; Miles P Davenport
Journal:  J Infect Dis       Date:  2015-11-03       Impact factor: 5.226

4.  Mathematical Modeling of Within-Host, Untreated, Cytomegalovirus Infection Dynamics after Allogeneic Transplantation.

Authors:  Elizabeth R Duke; Florencia A T Boshier; Michael Boeckh; Joshua T Schiffer; E Fabian Cardozo-Ojeda
Journal:  Viruses       Date:  2021-11-16       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.